EP Patent

EP2167069B1 — Cholesterol-interacting layered phyllosilicates and methods of reducing hypercholesteremia in a mammal

Assigned to Amcol International Corp · Expires 2011-10-26 · 15y expired

What this patent protects

Layered phyllosilicates are useful for adsorbing and/or binding to cholesterol and, thereby, reducing blood cholesterol in a patient. Accordingly, provided herein is a hydrogen protonated layered phyllosilicate material for use in a method of decreasing the solubility of choleste…

USPTO Abstract

Layered phyllosilicates are useful for adsorbing and/or binding to cholesterol and, thereby, reducing blood cholesterol in a patient. Accordingly, provided herein is a hydrogen protonated layered phyllosilicate material for use in a method of decreasing the solubility of cholesterol in the gastrointestinal tract of a mammalian subject.

Drugs covered by this patent

Patent Metadata

Patent number
EP2167069B1
Jurisdiction
EP
Classification
—
Expires
2011-10-26
Drug substance claim
No
Drug product claim
No
Assignee
Amcol International Corp
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.